India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
29/05/2026 05:26
BUZZ-India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH ** Shares of Wockhardt WCKH.NS rise 8.2% to 1,915.50 rupees
** Indian drug regulator grants marketing authorisation to Wockhardt's antibiotic ZAYNICH for treatment of complicated urinary tract infections
** Trading vols over 1x the 30-day average at 2.5 mln shares so far
** YTD, WCKH up ~32%
(Reporting by Vijay Malkar)
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter